(Q45104044)

9 December 2017

Acute lymphoblastic leukemia in India: an analysis of prognostic factors using a single treatment regimen (English)

1 reference

9 December 2017

1 reference

1 reference

lymphoblastic leukemia

1 reference

S Advani

1

1 reference

9 December 2017

S Pai

2

1 reference

9 December 2017

D Venzon

3

1 reference

9 December 2017

M Adde

4

1 reference

9 December 2017

P K Kurkure

5

1 reference

9 December 2017

C N Nair

6

1 reference

9 December 2017

B Sirohi

7

1 reference

9 December 2017

S D Banavali

8

1 reference

9 December 2017

R Hawaldar

9

1 reference

9 December 2017

B B Kolhatkar

10

1 reference

9 December 2017

T Vats

11

1 reference

9 December 2017

I Magrath

12

1 reference

9 December 2017

1 February 1999

1 reference

9 December 2017

1 reference

9 December 2017

10

1 reference

9 December 2017

2

1 reference

9 December 2017

167-176

1 reference

Lessons from 20 years of curative therapy of childhood acute leukaemia

9 December 2017

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008366814109

7 January 2021

Progress in the treatment of childhood leukaemias

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008366814109

7 January 2021

Risk-directed therapy for childhood acute lymphoblastic leukemia. Results of the Associazione Italiana Ematologia Oncologia Pediatrica '82 studies

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008366814109

7 January 2021

https://api.crossref.org/works/10.1023%2FA%3A1008366814109

1 reference

7 January 2021

Treatment of acute lymphoblastic leukemia. 30 years' experience at St. Jude Children's Research Hospital

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008366814109

7 January 2021

Acute lymphoblastic leukemia: end-result analysis of treatment and prognostic factors in Indian patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008366814109

7 January 2021

Four-agent induction/consolidation therapy for childhood acute lymphoblastic leukemia: an Indian experience

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008366814109

7 January 2021

An analysis of prognostic variables in acute lymphocytic leukaemia in a heterogenous South African population

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008366814109

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008366814109

7 January 2021

Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008366814109

7 January 2021

Descriptive epidemiology of lymphoid and haemopoietic malignancies in Bangalore, India

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008366814109

7 January 2021

Pattern of subtypes of acute lymphoblastic leukemia in India

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008366814109

7 January 2021

Immunological subtypes of acute lymphoblastic leukemia in north India

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008366814109

7 January 2021

Immunophenotypic analysis of T-cell acute lymphoblastic leukaemia in Madras, India

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008366814109

7 January 2021

Leukaemia and nutrition. I: Malnutrition is an adverse prognostic factor in the outcome of treatment of patients with standard-risk acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008366814109

7 January 2021

Malnutrition as a prognostic factor in lymphoblastic leukaemia: a multivariate analysis

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008366814109

7 January 2021

Improved outcome with delayed intensification for children with acute lymphoblastic leukemia and intermediate presenting features: a Childrens Cancer Group phase III trial.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008366814109

7 January 2021

Prognostic variables and survival in pediatric acute lymphoblastic leukemias: cancer institute experience.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008366814109

7 January 2021

Modified BFM protocol for childhood acute lymphoblastic leukemia: a retrospective analysis

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008366814109

7 January 2021

Standard and intermediate risk acute lymphoblastic leukemia in Poland: a report of the Polish Children's Leukemia/Lymphoma Study Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008366814109

7 January 2021

Treatment of patients with acute lymphoblastic leukemia with bulky extramedullary disease and T-cell phenotype or other poor prognostic features: randomized controlled trial from the Children's Cancer Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008366814109

7 January 2021

Lymphomatous presentation of childhood acute lymphoblastic leukemia. A subgroup at high risk of early treatment failure

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008366814109

7 January 2021

Genetic studies of childhood acute lymphoblastic leukemia with emphasis on p16, MLL, and ETV6 gene abnormalities: results of St Jude Total Therapy Study XII

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008366814109

7 January 2021

Philadelphia chromosome-positive acute lymphoblastic leukemia in children: durable responses to chemotherapy associated with low initial white blood cell counts

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008366814109

7 January 2021

Augmented Berlin-Frankfurt-Munster therapy abrogates the adverse prognostic significance of slow early response to induction chemotherapy for children and adolescents with acute lymphoblastic leukemia and unfavorable presenting features: a report fr

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008366814109

7 January 2021

Acute lymphoblastic leukemia in children: nonrandomized comparison of conventional vs. intensive chemotherapy at the National Cancer Institute of Colombia.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008366814109

7 January 2021

Identifiers

DOI

10.1023/A:1008366814109

1 reference

9 December 2017

1 reference